Dyne Therapeutics, Inc.
Index- P/E- EPS (ttm)-3.54 Insider Own0.90% Shs Outstand51.68M Perf Week-3.29%
Market Cap680.37M Forward P/E- EPS next Y-3.74 Insider Trans0.00% Shs Float50.91M Perf Month10.71%
Income-182.30M PEG- EPS next Q-0.97 Inst Own- Short Float2.50% Perf Quarter46.82%
Sales- P/S- EPS this Y-122.50% Inst Trans0.70% Short Ratio4.79 Perf Half Y23.52%
Book/sh5.55 P/B2.33 EPS next Y-11.50% ROA-45.00% Target Price25.83 Perf Year-17.92%
Cash/sh5.54 P/C2.33 EPS next 5Y- ROE-51.90% 52W Range4.30 - 16.39 Perf YTD8.66%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-21.17% Beta-
Dividend %- Quick Ratio11.60 Sales past 5Y- Gross Margin- 52W Low200.47% ATR1.00
Employees108 Current Ratio11.60 Sales Q/Q- Oper. Margin- RSI (14)51.31 Volatility5.53% 8.47%
OptionableYes Debt/Eq0.00 EPS Q/Q-73.00% Profit Margin- Rel Volume0.38 Prev Close12.90
ShortableYes LT Debt/Eq0.00 EarningsAug 04 BMO Payout- Avg Volume265.15K Price12.92
Recom1.70 SMA20-5.04% SMA506.50% SMA20040.62% Volume100,475 Change0.16%
Jul-20-22Initiated Chardan Capital Markets Buy $17
Jul-12-22Initiated Raymond James Outperform $15
Oct-12-20Initiated Stifel Buy $29
Oct-12-20Initiated Piper Sandler Overweight $34
Oct-12-20Initiated JP Morgan Overweight $27
Oct-12-20Initiated Jefferies Buy $47
Sep-27-22 07:30AM
Sep-12-22 07:00AM
Sep-06-22 04:30PM
07:30AM Loading…
Aug-29-22 07:30AM
Aug-10-22 07:30AM
Aug-04-22 07:30AM
Jul-18-22 10:00AM
Jul-12-22 02:54PM
Jul-05-22 07:30AM
Jul-01-22 06:58AM
Jun-03-22 07:30AM
May-16-22 07:30AM
04:05PM Loading…
May-02-22 04:05PM
Mar-17-22 08:45AM
Mar-10-22 07:30AM
Mar-03-22 07:30AM
Feb-02-22 01:38PM
Jan-22-22 08:06AM
Jan-18-22 04:18PM
Jan-05-22 07:30AM
Dec-03-21 03:30PM
Dec-02-21 08:30AM
Nov-04-21 07:30AM
Oct-26-21 10:41AM
Oct-13-21 07:45AM
Oct-01-21 10:21AM
07:30AM Loading…
Sep-28-21 07:30AM
Sep-27-21 07:30AM
Sep-20-21 07:30AM
Aug-05-21 07:30AM
Jul-26-21 03:00AM
Jun-25-21 07:30AM
Jun-02-21 04:05PM
May-26-21 07:30AM
May-14-21 02:44PM
May-06-21 07:29AM
Apr-27-21 04:35PM
Mar-04-21 07:35AM
Feb-08-21 07:30AM
Jan-27-21 01:13AM
Jan-20-21 08:05PM
Jan-10-21 03:00PM
Jan-05-21 07:30AM
Dec-08-20 10:17AM
Nov-09-20 07:30AM
Nov-05-20 07:35AM
Oct-09-20 03:41PM
Sep-21-20 04:05PM
Sep-16-20 07:00PM
Dec-13-19 03:38PM
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scalzo Richard WilliamSee RemarksMar 11Sale8.733082,68926,994Mar 14 05:09 PM
HIGH SUSANNA GATTIChief Operating OfficerMar 11Sale8.737656,67873,003Mar 14 05:08 PM
McNeill JonathanSee RemarksMar 11Sale8.734814,19960,466Mar 14 05:09 PM
Brumm Joshua TSee RemarksMar 11Sale8.733,38429,542210,324Mar 14 05:07 PM
Farwell WildonChief Medical OfficerMar 11Sale8.736405,58766,050Mar 14 05:08 PM
Beskrovnaya OxanaChief Scientific OfficerMar 11Sale8.736936,05053,676Mar 14 05:06 PM
Farwell WildonChief Medical OfficerMar 02Sale8.565,61748,08266,690Mar 03 07:22 PM